1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
- Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome
- Active conventional treatment and three different biological treatments in early rheumatoid arthritis : Phase IV investigator initiated, randomised, observer blinded clinical trial
- 2017
- Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients
- 2016
- Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
- 2011
- Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome
- Ten years with biologics: to whom do data on effectiveness and safety apply?
- 2009
- Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
- 2008
- The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
- 2007
- Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists